Episode
Discussing PsA: Bimekizumab in PsA: Clinical efficacy and updated safety profile
- Podcast
- The IMID Forum
- Published
- Apr 14, 2026
- Duration seconds
- 992
- Processing state
not_requested- Canonical source
- https://soundcloud.com/imidforum/discussing-psa-bimekizumab-in
Actions
POST https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-psa-bimekizumab-in-psa-clinical-efficacy-and-updated-safety-profile/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-imid-forum-981476/discussing-psa-bimekizumab-in-psa-clinical-efficacy-and-updated-safety-profile.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Join Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered the ‘safety and clinical efficacy of bimekizumab in patients with active PsA who were bDMARD-naïve or TNFi-IR, and the second provided a comprehensive and updated overview of bimekizumab’s safety profile to support clinical decision-making.